Literature DB >> 1295090

Dyslipoproteinemia in the course of active rheumatoid arthritis.

M B Lazarevic1, J Vitic, V Mladenovic, B L Myones, J L Skosey, W I Swedler.   

Abstract

Concentrations of serum lipids and serum very low-density lipoproteins and low-density lipoproteins (VLDL+LDL, originally called beta lipoproteins) were measured and agarose gel electrophoresis of serum lipoproteins was performed in 69 patients with active rheumatoid arthritis (RA), 40 patients with psoriatic arthritis (PA), 21 patients with osteoarthritis (OA), and 65 healthy blood donors. These lipid parameters were also compared in 21 RA and 40 PA patients during periods of severe disease activity (SA) versus minimal disease activity (MA). RA patients had significantly decreased concentrations of total serum lipids, total serum cholesterol, cholesterol in LDL, and cholesterol in high-density lipoproteins (HDL) compared with healthy blood donors. RA patients with SA had significantly decreased cholesterol in LDL and HDL compared with patients with MA. As the disease activity decreased, RA patients had normalization of almost all serum lipid concentrations. Electrophoresis of serum lipoproteins showed heterogeneous patterns in RA patients. Patients with PA also had some evidence of dyslipoproteinemia. Serum lipids changed with disease activity in PA patients in a manner similar to that in RA patients. These data show that patients with RA and PA have a dyslipoproteinemia that is related to disease activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295090     DOI: 10.1016/0049-0172(92)90017-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  31 in total

Review 1.  Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Authors:  Lotus Mallbris; Christopher T Ritchlin; Mona Ståhle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

2.  Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis.

Authors:  V P van Halm; J C van Denderen; M J L Peters; J W R Twisk; M van der Paardt; I E van der Horst-Bruinsma; R J van de Stadt; M H M T de Koning; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2006-04-27       Impact factor: 19.103

Review 3.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

4.  Dyslipidemia and rheumatoid arthritis.

Authors:  R D Situnayake; G Kitas
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

5.  Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.

Authors:  Katherine P Liao; Jun Liu; Bing Lu; Daniel H Solomon; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

6.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.

Authors:  P Alvarez; F Genre; M Iglesias; J J Augustin; E Tamayo; J C Escolà-Gil; B Lavín; F Blanco-Vaca; R Merino; J Merino
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

7.  Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Authors:  Calin Popa; Frank H J van den Hoogen; Timothy R D J Radstake; Mihai G Netea; Agnes E Eijsbouts; Martin den Heijer; Jos W M van der Meer; Piet L C M van Riel; Anton F H Stalenhoef; Pilar Barrera
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

8.  Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study.

Authors:  Gabriel Chodick; Howard Amital; Yoav Shalem; Ehud Kokia; Anthony D Heymann; Avi Porath; Varda Shalev
Journal:  PLoS Med       Date:  2010-09-07       Impact factor: 11.069

9.  Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls.

Authors:  Katherine P Liao; Dorothée Diogo; Jing Cui; Tianxi Cai; Yukinori Okada; Vivian S Gainer; Shawn N Murphy; Namrata Gupta; Daniel Mirel; Ashwin N Ananthakrishnan; Peter Szolovits; Stanley Y Shaw; Soumya Raychaudhuri; Susanne Churchill; Isaac Kohane; Elizabeth W Karlson; Robert M Plenge
Journal:  Ann Rheum Dis       Date:  2013-05-28       Impact factor: 19.103

10.  Plasma lipids and lipoproteins in juvenile chronic arthritis.

Authors:  A Bakkaloglu; B Kirel; S Ozen; U Saatçi; N Beşbaş
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.